Showing results (431-440 of 5,042) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|July 18, 2021
Does health-related quality of life differ between people with relapse onset and progressive onset Multiple Sclerosis?Hasnat Ahmad, Ingrid van der Mei, Bruce Taylor, et al.
Multiple Sclerosis and Related Disorders|July 18, 2021
Work productivity trajectories of Australians living with multiple sclerosis: A group-based modelling approachBarnabas Bessing, Mohammad A Hussain, Suzi B Claflin, et al.
Multiple Sclerosis and Related Disorders|July 24, 2021
Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online surveyTobia Zanotto, Mikaela L Frechette, Stephen R Koziel, et al.
Multiple Sclerosis and Related Disorders|July 14, 2021
Conus medullaris involvement in demyelinating disorders of the CNS: A comparative studyMasoud Etemadifar, Mehri Salari, Parisa K Kargaran, et al.
Multiple Sclerosis and Related Disorders|July 14, 2021
Oral pulsed therapy of relapsing multiple sclerosis with cladribine tablets - expert opinion on issues in clinical practiceMartin Stangel, Veit Becker, Birte Elias-Hamp, et al.
Multiple Sclerosis and Related Disorders|December 8, 2020
Usage trend of oral drugs for multiple sclerosis patients in ArgentinaRicardo Alonso, Orlando Garcea, María Barbara Eizaguirre, et al.
Multiple Sclerosis and Related Disorders|December 28, 2020
Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient RegistryEspen Benjaminsen, Kjell-Morten Myhr, Nina Grytten, et al.
Multiple Sclerosis and Related Disorders|December 28, 2020
Late-onset Leber's hereditary optic neuropathy presenting with longitudinally extensive myelitis harbouring the m.14484T>C mutation: Extending the genotype-phenotype spectrumJonathan Cleaver, Hamish Morrison, Gavin Reynolds, et al.
Multiple Sclerosis and Related Disorders|December 14, 2020
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trialJacqueline Palace, Dean M Wingerchuk, Kazuo Fujihara, et al.
Multiple Sclerosis and Related Disorders|December 14, 2020
Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trialAliyeh Bazi, Seyed Mohammad Baghbanian, Monireh Ghazaeian, et al.
Pageof 505